13/10/2025 (Agence Europe) – On Monday 13 October, the European Commission and the European Investment Bank (EIB) announced a partnership with the German biotech company BioNTech to build a messenger RNA vaccine manufacturing plant in Kigali, Rwanda. The project will benefit from a €35 million grant from the Commission and a potential €60 million loan from the EIB. The facility will produce vaccines against malaria, tuberculosis, HIV and simian smallpox (mpox), subject to...